EPISODE · Mar 17, 2025 · 30 MIN
Chronic Myeloid Leukemia: A 2025 Update on Novel Targets and Recent Clinical Data
from Keeping Current CME
How do STAMP inhibitors differ from ATP-competitive tyrosine kinase inhibitors (TKIs) when treating chronic myeloid leukemia (CML)? Credit available for this activity expires: 03/13/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-myeloid-leukemia-2025-update-novel-targets-and-2025a10005pm?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Chronic Myeloid Leukemia: A 2025 Update on Novel Targets and Recent Clinical Data
0:00
30:42
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 30 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 17, 2025.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!